Previous Article | Next Article ![]()
Clinical and Diagnostic Laboratory Immunology, 03 1997, 127-132, Vol 4, No. 2
MP Nair, SA Schwartz, R Polasani, J Hou, A Sweet and KC Chadha
It is now well established that parenteral drug abuse is a significant risk
factor for contracting human immunodeficiency virus type 1 (HIV-1)
infection and subsequently developing AIDS. Earlier studies have shown that
morphine can modulate various immune responses and therefore support the
premise that morphine is a cofactor in susceptibility to and progression of
HIV infection. Dysregulation of interferon (IFN) production, nonspecific
apoptosis of T cells, and the immune response to soluble HIV gene products
have been associated with potential mechanisms of pathogenesis in HIV
disease. The present study was undertaken to examine the immunomodulatory
role of morphine on HIV protein-induced lymphocyte proliferative responses,
Sendai and Newcastle disease virus-induced alpha IFN (IFN-alpha) and
IFN-beta production by lymphocytes and fibroblast cells, respectively, and
induction of apoptosis of normal lymphocytes in vitro. Our results
demonstrate that HIV protein-induced human lymphocyte proliferative
responses were significantly inhibited by morphine in a dose-dependent
manner. Furthermore, morphine significantly inhibited both IFN-alpha and
IFN-beta production by normal lymphocytes and fibroblasts but induced
apoptosis of normal lymphocytes. Inhibition of IFN-alpha production by
morphine could be reversed by the opiate receptor antagonist naloxone. This
suggests that the immunomodulatory effects of morphine are mediated through
the opioid receptor. These studies support a role of morphine as a cofactor
in the pathogenesis of HIV infection and describe some of the possible
pathologic mechanisms which underlie the immunoregulatory effects of
morphine.
Copyright © 1997 by the American Society for Microbiology. All rights reserved.
Immunoregulatory effects of morphine on human lymphocytes
Department of Medicine, Buffalo General Hospital, State University of New York at Buffalo 14203, USA.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. | Infect. Immun. |
|---|---|---|
| J. Clin. Microbiol. | J. Virol. | ALL ASM JOURNALS |